These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33141794)

  • 21. Treatment methods for extravasations of chemotherapeutic agents: a comparative study.
    Loth TS; Eversmann WW
    J Hand Surg Am; 1986 May; 11(3):388-96. PubMed ID: 3711613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extravasation of chemotherapeutic agents: prevention and treatment.
    Goolsby TV; Lombardo FA
    Semin Oncol; 2006 Feb; 33(1):139-43. PubMed ID: 16473651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center.
    Ehmke N
    Clin J Oncol Nurs; 2021 Dec; 25(6):680-686. PubMed ID: 34800094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extravasation of systemic hemato-oncological therapies.
    Ener RA; Meglathery SB; Styler M
    Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eliminating extravasation events: a multidisciplinary approach.
    Coyle CE; Griffie J; Czaplewski LM
    J Infus Nurs; 2014; 37(3):157-64. PubMed ID: 24694509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.
    Curtit E; Chaigneau L; Pauchot J; Nguyen T; Nerich V; Bazan F; Thiery-Vuillemin A; Demarchi M; Pivot X; Villanueva C
    Anticancer Res; 2012 Apr; 32(4):1481-3. PubMed ID: 22493389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model.
    Shibata Y; Sagara Y; Yokooji T; Taogoshi T; Tanaka M; Hide M; Matsuo H
    Biol Pharm Bull; 2018; 41(6):951-956. PubMed ID: 29863084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eliminating Extravasation Events: A Multidisciplinary Approach.
    Coyle CE; Griffie J; Czaplewski LM
    J Infus Nurs; 2015; 38 Suppl 6():S43-50. PubMed ID: 26536412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineoplastic vesicant extravasation.
    Beason R
    J Intraven Nurs; 1990; 13(2):111-4. PubMed ID: 2313459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extravasation of cytostatic drugs].
    Pikó B; Puskásné Szatmári K; Bassam A; Csiffári M; Dimák S; Szabó Z; Ocsai H; Csotye J
    Magy Onkol; 2011 Mar; 55(1):4-13. PubMed ID: 21617786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of perivascular extravasation of cytostatic agents].
    Rauh J; Pluntke S; Müller Ch
    MMW Fortschr Med; 2004 Aug; 146(31-32):23-4, 26-7. PubMed ID: 15529703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extravasation of chemotherapeutic agents: prevention and therapy].
    Jordan K; Grothe W; Schmoll HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and treatment of chemotherapy extravasation injuries.
    Kassner E
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):135-48. PubMed ID: 10944862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicant extravasation: myths and realities.
    Boyle DM; Engelking C
    Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytostatic drug extravasation--are there new recommendations for therapeutic management?].
    Fenchel K; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):44-6. PubMed ID: 11789418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
    Sauerland C; Engelking C; Wickham R; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and management of extravasation of cytotoxic drugs.
    Bertelli G
    Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic extravasation: an issue disappearing or a problem without solution?
    Ferrari LA; Dinoi GL; Saibene G; Re B; Balzarini A; Giordano L; Sala E; Bregant C
    Tumori; 2016 Jun; 2016(3):290-3. PubMed ID: 27032703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicant characteristics of oxaliplatin following antecubital extravasation.
    Kennedy JG; Donahue JP; Hoang B; Boland PJ
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):237-9. PubMed ID: 12924452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.